John Saringer

John Saringer is the CEO of Golden Horseshoe Life Sciences Inc. (formerly Venowave Inc.) and he presented to us Venowave, a Novel Venous-return Assist Device. This device is aimed at post thrombotics syndrome, where there is swelling and pain, by allowing blood to flow. Currently they are prototyping, and clinical trials have been successful and published. John Saringer gave us this important point when working with the FDA and Health Canada: “The FDA and Health Canada wants a final product, and not a prototype”. So far clinical trials are still ongoing with this new product, and eventually Venowave will want to be a self financing company. Read more about Venowave here.

Tools: | Print | Email